Carpila, Baby Girl .
HRN: 26-44-51 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/01/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/01/2025
01/08/2025
IV
42mg
Q24hrs
Neonatal Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes